Inovio Pharmaceuticals
INO
#8857
Rank
NZ$0.25 B
Marketcap
NZ$3.74
Share price
-0.46%
Change (1 day)
-46.23%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): NZ-$4.80

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.96. In 2024 the company made an earnings per share (EPS) of NZ-$6.80 an increase over its 2023 EPS that were of NZ-$10.48.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.80-29.34%
2024NZ-$6.80-35.14%
2023NZ-$10.48-56.62%
2022NZ-$24.17-19.54%
2021NZ-$30.0335.9%
2020NZ-$22.10-11.57%
2019NZ-$24.9915.24%
2018NZ-$21.69-2.78%
2017NZ-$22.316.93%
2016NZ-$20.86134.88%
2015NZ-$8.88-29.51%
2014NZ-$12.60-57.34%
2013NZ-$29.54146.55%
2012NZ-$11.9820.83%
2011NZ-$9.91-29.41%
2010NZ-$14.04-48.48%
2009NZ-$27.2610%
2008NZ-$24.7911.11%
2007NZ-$22.31-41.3%
2006NZ-$38.00-66.91%
2005NZ-$114.84110.61%
2004NZ-$54.53-61.63%
2003NZ-$142.10186.67%
2002NZ-$49.57
2001N/A-100%
2000NZ-$39.66-63.64%
1999NZ-$109.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.96-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$17.97-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ-$2.15-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.67-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$13.07-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.19-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
NZ$11.22-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA